tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kindstar Globalgene Faces Revenue and Profit Decline

Kindstar Globalgene Faces Revenue and Profit Decline

Kindstar Globalgene Technology, Inc. (HK:9960) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Kindstar Globalgene Technology, Inc. reported a decrease in revenue and net income for the first half of 2024 compared to the previous year, with a notable absence of COVID-19-related testing revenue. Gross profit margin declined due to investment in new products and expansion, contributing to a significant 75.8% drop in net income and a decrease in net margin from 8.8% to 2.2%.

For further insights into HK:9960 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1